Clinicopathological significance and prognostic effect of CD133 expression in invasive ductal breast carcinoma
Conclusion
CD133 was overexpressed in breast cancers with aggressive features.
Source: Egyptian Journal of Pathology - Category: Pathology Tags: ORIGINAL ARTICLES Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | Chemotherapy | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Egypt Health | Mastectomy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Pathology | Statistics | Stem Cell Therapy | Stem Cells | Study | Women